S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial.
about
S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDSS-adenosyl methionine (SAM-e) for depression in adultsCobalamin deficiency, hyperhomocysteinemia, and dementiaDo bartonella infections cause agitation, panic disorder, and treatment-resistant depression?Treatment of depression: time to consider folic acid and vitamin B12Treatment of advanced Parkinson's diseaseNatural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research.Homocysteine levels in schizophrenia and affective disorders-focus on cognition.S-adenosyl methionine (SAMe) for depression in adults.The role of vitamins and minerals in psychiatryAntidepressant studies in Parkinson's disease: a review and meta-analysis.Treatment of behavioural symptoms and dementia in Parkinson's disease.Management of the behavioral aspects of Parkinson's disease.Mood disorders and complementary and alternative medicine: a literature review.S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension.
P2860
Q21260290-BF626D72-F99B-4A57-9EAA-3658A40C7270Q24194039-CE97FDD5-8BD8-40D0-AA99-4F88B298E82DQ24609123-E6084068-26B0-4C4E-9597-BA1B0FEA3C21Q24684318-66D0152F-4327-4D0E-90DC-33480995DA7DQ28304306-E4C5DDEB-2795-41A6-BE76-59B7283AC86AQ30476968-182B345F-E8E8-44F5-B79D-47BE2E7C8544Q33946426-4FF73CE3-02BF-4098-9556-D20A045B0747Q34292122-EA4F2513-8B5C-48AF-AEDA-F36DB9106BD3Q34542360-792FCA6C-849A-4FDF-BA00-9183165B56E1Q34611434-3EBF0C2C-7AAB-4C86-88FB-5A8A5A6DAD53Q36008775-0347226C-C305-4965-A925-712386BA5874Q36089350-CCAB485D-3C42-4EA2-B1B9-C1A4EA5FD1D7Q36847271-9DE96C3B-2CE4-4DB7-9835-C9950F6116DCQ36863056-EC0BFF1B-9040-4274-9ACB-040D79B39267Q38691239-8A20E4D4-BEE5-4530-BD6B-83560E7E6DC7Q45873810-7A838B07-FAEA-473C-9C3E-F1A17FA5659AQ46220313-8D0A85F2-EBD3-4F1F-8EBB-97403AB6B9EA
P2860
S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
S-Adenosyl-Methionine improves ...... an open-label clinical trial.
@en
S-Adenosyl-Methionine improves ...... an open-label clinical trial.
@nl
type
label
S-Adenosyl-Methionine improves ...... an open-label clinical trial.
@en
S-Adenosyl-Methionine improves ...... an open-label clinical trial.
@nl
prefLabel
S-Adenosyl-Methionine improves ...... an open-label clinical trial.
@en
S-Adenosyl-Methionine improves ...... an open-label clinical trial.
@nl
P2093
P2860
P1433
P1476
S-Adenosyl-Methionine improves ...... n an open-label clinical trial
@en
P2093
P2860
P304
P356
10.1002/1531-8257(200011)15:6<1225::AID-MDS1025>3.0.CO;2-A
P407
P577
2000-11-01T00:00:00Z